Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Aparna Goel
Age
14–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of primary sclerosing cholangitis confirmed by liver biopsy and/or imaging study
If history of endoscopically confirmed inflammatory bowel disease, currently stable based on Mayo Score / Disease Activity Index (DAI) for Ulcerative Colitis Score ≤ 1, normal inflammatory markers (ESR, CRP and fecal calprotectin) and stable non-excluded medical therapy for at least 6 months
You may not be if
Currently receiving biologic therapies
Known allergy to hymecromone
Cholangiocarcinoma
Pregnancy
Serious liver disease
Clareo Health | Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.
